Drawing for DAEWOONG PHARMACEUTICAL CO., LTD.

USPTO serial 77004855

DAEWOONG PHARMACEUTICAL CO., LTD.

Reviewed by CopyMark Law Group

Reg. 3966537Status 710
Filing date
Status date
Registration date
May 24, 2011
Examiner
MITTLER, ROBIN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DAEWOONG PHARMACEUTICAL CO., LTD.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelly Phair McCarthy

KELLY PHAIR MCCARTHY SIDEMAN & BANCROFT LLPONE EMBARCADERO CENTER8TH FLOORSAN FRANCISCO, CA 94111

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, acetaminophen, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; dietary and nutritional supplements; medicated skin lotions, bandages for skin wounds, vitamins; biological preparations for medical purposes; all purpose disinfecting and deodorizing preparations; pharmaceutical preparations for use in cardiovascular treatment; diagnostic agents for medical purposes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations to prevent swelling in the legs; pharmaceutical preparations for treating respiratory diseases and asthma; pharmaceutical preparations for the treatment of erectile dysfunction; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; processed food adapted for medical purposes; plant extracts adapted for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; plant extracts adapted for use in chemotherapy; veterinary preparations for treatment of intestinal bacteria in mammals; veterinary preparations, namely, vaccines; sanitary preparations for medical useSECTION 8 - CANCELLEDOct 1, 2010
035Pharmaceutical sales promotion for others; providing business information for pharmaceuticals; business management assistance on pharmaceuticals; market research; market study; advertising services; arranging of pharmaceutical sale, namely, procuring of contracts for the purchase and sale of pharmaceuticals, retail services by direct solicitation by sales agents in the field of pharmaceuticals; export-import agency; retail store services in the field of health supplements, retail services by direct solicitation by sales agents in the field of health supplements; retail store services in the field of cosmetics, retail services by direct solicitation by sales agents in the field of cosmetics; and procurement services, namely, purchasing pharmaceuticals for othersSECTION 8 - CANCELLEDNov 1, 2009
044Medical clinics; pharmaceutical advice; preparation and dispensing of pharmaceuticals; technology services on selecting medicines, namely, interactive medical monitoring and alert services for reminding clients of medical information, namely, medicinal dosage, allergic sensitivity and prescription refills; providing medical information about medical equipment, devices and pharmaceutical preparations; clinical pathology services for the diagnosis and treatment of disease; medical assistance services; medical testing service; medical and health care, namely, ambulant medical care; cosmetic analysis; rental of medical equipment; rental of sanitary equipment, namely, clean chambers for sanitary purposes, urinals for sanitary fixtures, hand washing basins and bowls for sanitary installations and water pipes for sanitary installationsSECTION 8 - CANCELLEDNov 1, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 29, 2017C8..CANCELLED SEC. 8 (6-YR)—
May 24, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 20, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 19, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 19, 2011ALIEASSIGNED TO LIE—
Apr 5, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 14, 2011EX5GSOU EXTENSION 5 GRANTED—
Mar 10, 2011IUAFUSE AMENDMENT FILED—
Mar 10, 2011EXT5SOU EXTENSION 5 FILED—
Mar 10, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 15, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2010EX4GSOU EXTENSION 4 GRANTED—
Sep 13, 2010EXT4SOU EXTENSION 4 FILED—
Sep 13, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2010EX3GSOU EXTENSION 3 GRANTED—
Mar 4, 2010EXT3SOU EXTENSION 3 FILED—
Mar 4, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 24, 2009EX2GSOU EXTENSION 2 GRANTED—
Sep 24, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 14, 2009EXT2SOU EXTENSION 2 FILED—
Sep 14, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2009EX1GSOU EXTENSION 1 GRANTED—
Mar 11, 2009EXT1SOU EXTENSION 1 FILED—
Mar 11, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 16, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 24, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 4, 2008NPUBNOTICE OF PUBLICATION—
May 22, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 16, 2008ALIEASSIGNED TO LIE—
May 15, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 9, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 9, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2008GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 21, 2008GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 21, 2008CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 21, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 28, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 18, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 4, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 4, 2008ALIEASSIGNED TO LIE—
Nov 19, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Nov 19, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 19, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 19, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 13, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 12, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2007GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 2, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 2, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 21, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 21, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2007DOCKASSIGNED TO EXAMINER—
Jan 17, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 28, 2006MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Sep 27, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance